India  

Spinal muscular atrophy

Rare congenital neuromuscular disorder

Spinal muscular atrophy    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Spinal muscular atrophy: Rare congenital neuromuscular disorder
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting. It is usually diagnosed in infancy or early childhood and if left untreated it is the most common genetic cause of infant death. It may also appear later in life and then have a milder course of the disease. The common feature is progressive weakness of voluntary muscles, with arm, leg and respiratory muscles being affected first. Associated problems may include poor head control, difficulties swallowing, scoliosis, and joint contractures.

0
shares
ShareTweetSavePostSend
 

You Might Like


Free SMA treatment for all to cost Rs 40,000 crore a year, not SC's call: Government

Centre informed Supreme Court that providing free gene therapy for Spinal Muscular Atrophy (SMA) could cost India Rs 35-40,000 crore annually. The government has capped free treatment costs at Rs 50..
IndiaTimes - Published

Health groups join patent war over spinal muscular atrophy drug

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug, Risdiplam. They argue that Roche's patent infringement lawsuit against..
IndiaTimes - Published

Karnataka CM Siddaramaiah appeals to PM Modi for lifesaving aid for toddler battling rare disease

Karnataka Chief Minister Siddaramaiah has requested assistance from PM Modi for the medical treatment of a 15-month-old boy with a rare disease. The CM has asked for financial support from the Centre..
IndiaTimes - Published

Search this site and the web: